Diabetes Drug Avandia Could Be Pulled from Market
By injuheis on July 27, 2010
On June 28, a study was released which showed a connection between Avandia, a diabetes drug made by GlaxoSmithKline, and increased risks of heart problems, strokes and deaths in older adults.
According to FoxNews.com, the study conducted a comprehensive review of over 200,000 Medicare patients who took Avandia. The study followed the patients, who were an average age of 74, for three years. The study showed that 100,000 deaths, strokes, heart attacks and cases of heart failure may be due to Avandia side effects. GlaxoSmithKline maintains that the drug is safe and claimed there were limits on the study which led to an improper result.
The study found that patients who used Avandia were 27 percent more likely to have a stroke, 14 percent more likely to die, and 25 percent more likely to have heart failure than individuals on Actos, a competitor to Avandia. The FDA plans to hold a hearing on Avandia, where it will hear testimony about the safety of the drug and decide what should be done. The drug could be pulled from the market or be required to display more warning labels.
Some dangerous prescription drugs can have deadly side effects, if not leave a patient with serious injury or newly developed health problems. If you or a loved one has been injured by an unsafe drug in Maryland, including Avandia, you should contact an experienced Maryland pharmaceutical litigation attorney immediately. A knowledgeable attorney can help you receive damages for your medical problems that arose because of the prescription drug. For a free consultation with Steven H. Heisler, “The Injury Lawyer,” call 877-228-4878 today.
Leave a Reply
You must be logged in to post a comment.